1. Home
  2. DOMO vs ABEO Comparison

DOMO vs ABEO Comparison

Compare DOMO & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DOMO
  • ABEO
  • Stock Information
  • Founded
  • DOMO 2010
  • ABEO N/A
  • Country
  • DOMO United States
  • ABEO United States
  • Employees
  • DOMO N/A
  • ABEO N/A
  • Industry
  • DOMO Computer Software: Prepackaged Software
  • ABEO Biotechnology: Pharmaceutical Preparations
  • Sector
  • DOMO Technology
  • ABEO Health Care
  • Exchange
  • DOMO Nasdaq
  • ABEO Nasdaq
  • Market Cap
  • DOMO 286.1M
  • ABEO 277.6M
  • IPO Year
  • DOMO 2018
  • ABEO 1980
  • Fundamental
  • Price
  • DOMO $7.77
  • ABEO $6.24
  • Analyst Decision
  • DOMO Hold
  • ABEO Strong Buy
  • Analyst Count
  • DOMO 5
  • ABEO 3
  • Target Price
  • DOMO $9.60
  • ABEO $18.00
  • AVG Volume (30 Days)
  • DOMO 281.9K
  • ABEO 220.1K
  • Earning Date
  • DOMO 11-29-2024
  • ABEO 11-11-2024
  • Dividend Yield
  • DOMO N/A
  • ABEO N/A
  • EPS Growth
  • DOMO N/A
  • ABEO N/A
  • EPS
  • DOMO N/A
  • ABEO N/A
  • Revenue
  • DOMO $318,369,000.00
  • ABEO N/A
  • Revenue This Year
  • DOMO $0.39
  • ABEO N/A
  • Revenue Next Year
  • DOMO N/A
  • ABEO $7,097.06
  • P/E Ratio
  • DOMO N/A
  • ABEO N/A
  • Revenue Growth
  • DOMO 0.19
  • ABEO 147.52
  • 52 Week Low
  • DOMO $6.11
  • ABEO $3.05
  • 52 Week High
  • DOMO $12.23
  • ABEO $9.01
  • Technical
  • Relative Strength Index (RSI)
  • DOMO 54.19
  • ABEO 49.81
  • Support Level
  • DOMO $7.39
  • ABEO $6.04
  • Resistance Level
  • DOMO $8.53
  • ABEO $6.78
  • Average True Range (ATR)
  • DOMO 0.32
  • ABEO 0.31
  • MACD
  • DOMO 0.03
  • ABEO -0.06
  • Stochastic Oscillator
  • DOMO 45.80
  • ABEO 36.49

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.

Share on Social Networks: